Last updated: February 21, 2026
What is the scope of JP2024014928?
Patent JP2024014928 is a Japanese patent application, filed recently, targeting specific inventions related to a pharmaceutical composition or drug. Its scope primarily encompasses the structure, formulation, and method of use of the claimed drug, with a focus on novel elements that differentiate it from prior art.
The document covers components, dosages, delivery mechanisms, or combination therapies that specify a new treatment method or compound. It emphasizes the chemical structure of active ingredients, their method of synthesis, or their administration route.
What are the key claims of JP2024014928?
The patent contains a set of claims designed to protect specific aspects of the invention. Typical claim categories include:
- Independent claims: Define the core invention. For JP2024014928, these likely cover a novel compound, a specific formulation, or a therapeutic method.
- Dependent claims: Narrow the scope, referencing independent claims and incorporating additional features such as specific chemical substitutions, dosage ranges, or device configurations.
Example of potential claims (hypothetical based on standard patent structure):
-
Claim 1: A pharmaceutical composition comprising a compound having the structure of [chemical formula], wherein the compound exhibits activity against [target disease or condition].
-
Claim 2: The composition of claim 1, further comprising a pharmaceutically acceptable carrier or excipient.
-
Claim 3: A method of treating [disease], comprising administering an effective amount of the composition of claim 1 to a patient in need.
-
Claim 4: A process for synthesizing the compound of claim 1, involving steps A, B, and C, specific to achieving high purity and yield.
Claim language considerations:
- Focuses on chemical structure, dosage, specific use, or delivery method.
- Uses legal language such as "comprising," "consisting of," and "wherein."
What does the patent landscape look like for this invention?
The patent landscape surrounding JP2024014928 involves prior patents and applications related to similar chemical entities, therapeutic methods, or delivery systems. Analyzing the landscape involves examining:
- Prior art references: Existing patents and publications that disclose similar compounds or methods.
- Filing trends: Recent filings in Japan and internationally, reflecting the R&D focus in specific therapeutic areas.
- Key patentholders: Companies or institutions active in the same field, indicating competitive landscape.
Major patent families and related applications:
| Patent Family |
Filing Country |
Key Innovator |
Priority Date |
Status |
| Family A |
Japan, US, Europe |
Company X |
2022-01-15 |
Pending/Granted |
| Family B |
Japan only |
Institution Y |
2021-12-01 |
Pending |
| Family C |
Japan, China |
Company Z |
2022-06-30 |
Application stage |
Global patent families suggest strategic protection in key markets, with a focus on North America, Europe, and China, reflecting commercial intentions.
Patentability considerations:
- Novel chemical compounds with unique substitutions or configurations.
- New therapeutic indications or combination therapies.
- Unique delivery systems improving bioavailability or patient adherence.
Overlapping patents and risks:
Patents in the same chemical class or disease indication could pose freedom-to-operate challenges. Potential overlaps involve patents claiming broad classes of compounds that might include the candidate molecule.
How does JP2024014928 compare with existing patents?
The patent appears to carve out specific chemical variants or formulations not disclosed previously. Its claims likely focus on a subset of compounds or uses that distinguish them from broader existing patents.
A landscape review indicates the patent's position as:
- Innovative: In targeting a new chemical structure or therapeutic application.
- Potentially Narrow: In claim language, depending on how broad the claims are drawn.
Competitors with existing claims on related compounds or methods may require licensing or designing around the patent.
Strategic considerations
- Patent robustness: The scope should ideally target protecting a novel chemical entity or use, with claims supported by experimental data.
- Filing strategy: Multiple jurisdictions under PCT or direct applications enhance global coverage.
- Competitive landscape: Monitoring filings from major players in the refractory disease or targeted therapy sectors informs potential patent conflicts.
Key Takeaways
- JP2024014928 claims a new chemical entity, formulation, or therapeutic method with specific claims around structure, formulation, or use.
- The patent landscape involves other patents in the same chemical class and therapeutic area, requiring detailed freedom-to-operate analysis.
- The patent's strength depends on claim clarity, novelty, and prior art landscape.
- Competitive risk exists if similar compounds are patented by major industry players.
- Securing core claims early in key jurisdictions enhances commercial positioning.
FAQs
1. How broad are the claims likely to be in JP2024014928?
Claims may focus narrowly on specific compounds or formulations, with broader claims potentially covering a chemical class. The actual breadth depends on patent application drafting and prior art.
2. What are common patent hurdles for pharmaceutical inventions in Japan?
Prior art searches often reveal similar compounds or uses. Patent examiners require demonstrable novelty and inventive step, often through experimental data or unique claim language.
3. Can similar patents block the commercialization of this invention?
Yes, existing patents claiming similar compounds or methods can restrict commercialization without licensing. A freedom-to-operate analysis is essential.
4. How does Japan's patent system impact pharmaceutical patent timing?
Japan grants patents typically within 12-18 months from filing, with examination periods extending up to three years. Provisional applications can fast-track certain filings.
5. What should applicants consider for global patent protection?
Applicants should file via PCT for broader coverage, targeting jurisdictions where the drug is intended for commercialization. Coordination with local patent attorneys enhances success.
References
- Japanese Patent Office. (2022). Japan Patent System. Retrieved from https://www.jpo.go.jp/e/system/patent/index.html
- WIPO. (2021). Patent Cooperation Treaty (PCT): Overview. Retrieved from https://www.wipo.int/pct/en/
- World Intellectual Property Organization. (2020). Patent Landscape Reports. Retrieved from https://www.wipo.int/competitive intelligence/en/landscape/
